Digestive & Travel

Zepbound®

starting at $1,379.99

Approved on November 8th, 2023, Zepbound® is an injectable prescription medication used to help reduce weight for adults that struggle keeping it off. It is indicated for individuals who are overweight, obese, or have medical conditions causing excessive weight gain. It is injected under the skin once weekly and may be increased based on clinical response and tolerance. Follow package instructions upon receiving the product. *This product is not eligible for discount*

A once weekly injection shown to reduce weight for overweight individuals when combined with diet and exercise

Lower doses can help minimize stomach upset and titration can be delayed based on tolerance

Injected in the upper arm, thigh, or abdomen rotating sites without regard to meals

Stored at refrigerated temperatures (2°C to 8°C)

Single pens may also be stored at temperatures no more than 86°F for up to 21 days

Must not be used with other medications containing the same active ingredient or within the same class, including Mounjaro, Ozempic, Trulicity, Saxenda, Victoza, Bydureon or Otezla

Refill

HSA/FSA Eligible

Zepbound®

H&P Certification

Tell us about yourself.

“You need to carefully review and make sure you can agree to each statement. If there are questions, a doctor will be in touch after checkout.”

Zepbound®

By clicking the “I Agree” button below, you certify under penalty of perjury that the following statements are true and correct and understand that a medical provider will rely on the truthfulness of your statements when determining whether a prescription is warranted and appropriate.

I agree that I:

am 18 years or older
have not had a hypersensitivity reaction to Zepbound® or any component of the formulation
do not have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2)
do not have pancreatitis
understand this medication may reduce the efficacy of birth control resulting in unplanned pregnancy
understand that there is limited data about the drug interactions between Zepbound® and other prescription medications, herbal products, and supplements
do not have Type 1 diabetes or diabetic ketoacidosis (DKA)
am not taking other medications with the same active ingredient or within the same class as Zepbound®, including but not limited to, Mounjaro, Ozempic, Trulicity, Saxenda, Victoza, Bydureon or Otezla
understand serious side effects of Zepbound® may include severe stomach issues, kidney failure, gallbladder problems, pancreatitis, low blood sugar, and changes in vision
am not taking insulin or sulfonylureas, such as glipizide or glyburide, which could increase the risk of low blood sugar
understand psychiatric effects have occurred, such as suicidal thoughts, with other medications for weight management
have not had bariatric surgery
understand this medication may slow gastric emptying which can alter the absorption of other medications
am not pregnant or breastfeeding
understand this is not a comprehensive list of precautions, risks, side effects, or details about taking this medication
understand that only major drug interactions are listed and have not been reviewed against the other medications, supplements, or herbal products I may be taking unless also filled by TelyRx

understand that TelyRx LLC does not provide medical care and the providers who use TelyRx to provide telehealth services (“Telehealth Providers”) should not replace your primary provider.
understand that the Telehealth Providers are not able to: (1) monitor ongoing health or lab values for side effects or efficacy, (2) observe how you (or your pet) tolerate any prescribed treatment, or (3) determine if the prescribed treatment is working as intended and assume any risks associated with this modality of care and waive any claim I may have in the future against TelyRx and/or the Telehealth Providers.
understand that by using this site, I have created a patient-client-doctor relationship and I am being directed by the Telehealth Providers to consult my primary provider soon after beginning any treatment prescribed by the Telehealth Providers.
understand that this is a supplemental mode of care for your convenience and the Telehealth Providers are not to be used, or relied on, as a replacement for in-person follow-up visits or interactions with your primary provider.

I agree that all statements above are true and my physician visit is complete.

Cancel

Web-form is not active.

Skip to the end of the images gallery

For illustration purposes only. Product appearance may vary based on manufacturer availability.

Skip to the beginning of the images gallery

Zepbound® Medication Description
Zepbound® injection (tirzepatide) is a prescription medication approved for chronic weight management in adults with obesity, or in adults who are overweight with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol. Zepbound is intended to be used together with a reduced-calorie diet and increased physical activity.

Tirzepatide works by mimicking the activity of two natural hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These hormones help regulate blood sugar, slow digestion, reduce appetite, and promote a feeling of fullness, supporting both improved metabolic control and sustained weight loss.

How to Use
- Zepbound® is typically prescribed as a once-weekly subcutaneous injection (under the skin) in the abdomen, thigh, or upper arm.
- Treatment usually begins with a lower starting dose and is gradually increased to improve tolerability.
- A common dosing approach begins at 2.5 mg once weekly, with stepwise increases every 4 weeks as directed by your healthcare provider, up to a maximum dose of 15 mg once weekly.
- Injections should be given on the same day each week, with or without food.
- Injection sites should be rotated with each dose, and a new needle should be used every time.
- If a dose is missed, your healthcare provider will advise whether to take it when remembered or to wait until the next scheduled dose.
Black Box Warning

Zepbound® (tirzepatide) carries a boxed warning for the risk of thyroid C-cell tumors. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in those with multiple endocrine neoplasia syndrome type 2 (MEN 2). Patients should promptly report symptoms such as a lump in the neck, hoarseness, difficulty swallowing, or shortness of breath.

Important Notes and Warnings
- The most common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite, especially during dose escalation.
- Serious but less common risks include pancreatitis, gallbladder disease, kidney injury (often related to dehydration), and possible worsening of diabetic retinopathy in patients with type 2 diabetes.
- Zepbound should not be used with other GLP-1 receptor agonists or medications containing tirzepatide.
- Not recommended during pregnancy; treatment should be discontinued at least 2 months before a planned pregnancy.
- Inform your healthcare provider about all medications you are taking, as Zepbound may delay gastric emptying and affect absorption of certain oral drugs.
- This medication is intended for long-term use as part of a comprehensive weight management program.
Zepbound® Side Effects

Zepbound side effects may include nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, injection site reactions, fatigue, allergic reactions and heartburn.
Consumer Information Use and Disclaimer

This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.